KLR Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,680
Closed -$218K 194
2023
Q3
$218K Sell
2,680
-1,886
-41% -$158K 0.2% 161
2023
Q2
$405K Buy
4,566
+1,749
+62% +$151K 0.33% 95
2023
Q1
$229K Sell
2,817
-2
-0.1% -$163 0.2% 160
2022
Q4
$221K Buy
+2,819
New +$228K 0.18% 159

Other funds holding MDT

KLR Investment Advisors's MDT Position: Q4 2023 in Review

KLR Investment Advisors sold out of Medtronic (MDT) in Q4 2023, closing a stake of 2,680 shares — an estimated $218K sold.

KLR Investment Advisors first reported a position in MDT in Q4 2022 and held it in 4 quarters. The position peaked at $405K in Q2 2023. 2,074 funds tracked by Wall St. Rank hold MDT as of Q4 2023.

  • KLR Investment Advisors reported no remaining Medtronic position as of Q4 2023 after selling out during the quarter.
  • KLR Investment Advisors sold 2,680 Medtronic shares in Q4 2023, an estimated $218K.
  • KLR Investment Advisors first reported a position in Medtronic in Q4 2022 and held it in 4 quarters.
  • KLR Investment Advisors's Medtronic position peaked at $405K in Q2 2023.
  • 2,074 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.

Based on KLR Investment Advisors's 13F filing for Q4 2023, filed 8 Feb 2024.